- Only OTC mouthwash proven as effective as a prescription rinse (CHX) and is safe for everyday use1*
- Powerful, broad spectrum germ-killing action of the 4 ESSENTIAL Oils is delivered throughout the mouth and deep into biofilm by the penetrating action of alcohol2**
- Only OTC brand of mouthwash with the ADA Seal of Acceptance
How does LISTERINE® Antiseptic penetrate and kill plaque biofilm?
LISTERINE® Antiseptic attacks bacteria and inhibits
regrowth using a fixed combination of 4 essential oils: eucalyptol, menthol, methyl salicylate, and thymol
- DAMAGES the bacterial cell surface3,4
- INTERFERES with biofilm growth5
- INCREASES the time it takes for bacteria to grow back3
LISTERINE® Antiseptic attacks and kills bacteria deep within the biofilm
Rinsing 30 seconds twice daily with 20 ml of
full-strength LISTERINE® Antiseptic yields greater bacterial kill and greater plaque reduction†
BEFORE
Scanning electron micrograph (SEM) of biofilm not treated with LISTERINE® Antiseptic
AFTER
SEM of biofilm treated with LISTERINE® Antiseptic
CLOSE-UP
SEM of ruptured bacterial cell wall in LISTERINE® Antiseptic-treated biofilm
Images courtesy of Christoph Schaudinn, PhD, University of Southern California School of Dentistry, Center for Biofilms.
How much deeper is the LISTERINE® Antiseptic clean?
Study confirms the powerful biofilm kill of LISTERINE® Antiseptic5
- In this lab model, saliva-derived biofilms were grown on saliva-coated glass slides
- Biofilms were cultured for 65 hours prior to mouthrinse exposure
- Biofilms were stained to enable quantification of the live/dead cells
Powerful biofilm kill without the side effects5-9
- Superior kill vs CPC-based rinses (0.05% to 0.07%) like CREST® PRO–HEALTH™, without the side effect of staining5,10
- Comparable kill vs CHX-containing rinses (0.12%) like PERIDEX™, without the side effects of staining and altered taste11
How does LISTERINE® Antiseptic help your patients achieve an overall healthier mouth?
In a long-term clinical study,
LISTERINE® Antiseptic showed comparable reduction of gingivitis at 6 months vs PERIDEX™1
- In this lab model, saliva-derived biofilms were grown on saliva-coated glass slides
- Biofilms were cultured for 65 hours prior to mouthrinse exposure
- Biofilms were stained to enable quantification of the live/dead cells
Powerful biofilm kill without the side effects5-9
- Superior kill vs CPC-based rinses (0.05% to 0.07%) like CREST® PRO–HEALTH™, without the side effect of staining5,10
- 52% greater plaque reduction at 6 months when added to brushing and flossing2
- 21% greater gingivitis reduction vs brushing and flossing2
- In a separate study, up to 70% greater plaque reduction was demonstrated with LISTERINE® Antiseptic vs brushing alone5
The ADA Council on Scientific Affairs' Acceptance of LISTERINE® Antiseptic is based on its finding that the product is effective in helping to prevent or reduce gingivitis and plaque above the gumline, when used as directed.††
return to home page
tartar removal.
** Data on file, McNEIL-PPC, Inc.
† vs. CREST® PRO-HEALTH™ Rinse in vitro.
†† ADVANCED LISTERINE® (Citrus or ARCTIC MINT®) does not carry the ADA Seal of Acceptance.
1. Overholser CD, Meiller TF, DePaola LG, Minah GE, Niehaus C. Comparative effects of 2 chemotherapeutic mouthrinses on the development of supragingival dental plaque and gingivitis. J Clin Periodontol 1990;17(8):575-579. 2. Sharma N, Charles CH, Lynch MC, et al. Adjunctive benefit of an essential oil-containing mouthrinse in reducing plaque and gingivitis in patients who brush and floss regularly: a six-month study. J Am Dent Assoc. 2004;135(4):496-504. 3. Fine DH, Furgang D, Lieb R, et al. Effects of sublethal exposure to an antiseptic mouthrinse on representative plaque bacteria. J Clin Periodontol. 1996;23(5):444-451. 4. Kubert D, Rubin M, Barnett ML, Vincent JW. Antiseptic mouthrinse-induced microbial cell surface alterations. Am J Dent. 1993;6(6):277-279. 5. Data on file, McNEIL-PPC, Inc. 6. Lux R, Pan SD, Castaneda JH, et al. Biocidal activity of antiseptic mouthrinses in saliva-derived biofilm model. Presented at: 86th General Session of the International Association for Dental Research; July 2-5, 2008; Toronto, Canada. Abstract 1339. 7. Pan P, Lux R, Shi W, et al. Evaluation of plaque biofilm kill activity of representative global mouthrinses. Presented at: American Association for Dental Research Annual Meeting; April 2-5, 2008; Dallas, TX. Abstract 0031. 8. Araujo MWB, Pan P, Lux R, Shi W. Plaque biofilm penetration by essential-oil and CPC containing mouthrinses. Presented at: 86th General Session of the International Association for Dental Research; July 2-5, 2008; Toronto, Canada. Abstract 0285. 9. Ricci-Nittel, Fourre T. Evaluation of antimicrobial mouthrinses using a microplate-based flow-through biofilm model. Presented at: 86th General Session of the International Association for Dental Research; July 2-5, 2008; Toronto, Canada. Abstract 0287. 10. Witt JJ, Isaacs RL, Mau M, et al. Efficacy of two experimental CPC mouthrinses in a 6-month study. Presented at: 83rd General Session of the International Association for Dental Research; March 9-12, 2005; Baltimore, MD. Abstract 3598. 11. Peridex™ (0.12% chlorhexidine gluconate) Oral Rinse [prescribing information]. St Paul, MN: 3M ESPE Dental Products; 2008.
